Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
Is Vaping Safe? This is probably a question that resurfaces every now and then after e-cigarettes made their way as an alternative to Nicotine Cigarettes. The results of the studies that have been concluded so far have been largely contradicting and confusing. None of the studies has ascertained a number of risks involved with Vaping e-cigarettes and a detailed comparative study with the traditional cigarettes so far.
However, one of the new studies funded by the Cancer Research UK has some bright result and conclusive answers. The research indicates that the chances of cancer for the e-cigarette smoker is comparatively very low than a normal smoker.
The tests were made on 181 people and the samples of Urine and Saliva were collected to conduct the research. The carcinogens or NNAL chemical in an e-cigarette is 97.5 percent lower than the traditional cigarette reported Daily Dot.
In long term, the effect of vaping would be much beneficial for the health than smoking reiterated Lion Shahab to Digital Trends, one of the scientists involved in the study. The research was also carried out on the NRT or Nicotine Replacement Therapy and the result was similar to that of the e-cigarettes.
This is big news for those who are already vaping instead of smoking or those who are planning to quit the combustible cigarette. E-cigarettes are pitched in the market with the promise of greater health benefits than traditional combustible cigarettes. Many types of research have supported the claim but no substantial approval of the study has been reported. The new tests can open up the new opportunities to determine the health risks and benefits of vaping over smoking.
However, the study does not include the other risk factors of smoking along with cancer. The reports suggest that the separate tests would be made to determine the risk factor and comparative study of the cardiovascular and respiratory risks.